Total planned funding: $659,624,542
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $168,932,672 |
| Uganda | $97,022,865 |
| Zambia | $82,676,822 |
| Mozambique | $74,006,526 |
| Côte d'Ivoire | $49,714,784 |
| Zimbabwe | $40,364,907 |
| Kenya | $33,270,138 |
| Tanzania | $27,937,960 |
| Vietnam | $20,600,000 |
| Haiti | $17,875,426 |
| Rwanda | $17,305,445 |
| Cameroon | $10,000,000 |
| South Africa | $7,532,043 |
| Botswana | $5,914,713 |
| Democratic Republic of the Congo | $3,285,759 |
| Guyana | $1,140,000 |
| Eswatini | $1,098,694 |
| Burundi | $742,114 |
| Cambodia | $50,217 |
| Dominican Republic | $48,986 |
| South Sudan | $31,572 |
| Ukraine | $25,824 |
| Ethiopia | $23,598 |
| India | $23,477 |
Organizational Types
| Private Contractor | $575,644,835 |
| NGO | $69,268,897 |
| Host Country Government Agency | $6,356,588 |
| Unknown | $5,781,518 |
| Own Agency | $1,719,053 |
| Other USG Agency | $569,897 |
| University | $147,054 |
| FBO | $136,700 |
| Implementing Agency | $0 |
Program Areas
| Treatment | $659,624,542 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $659,624,542 |
Top Partner Programs
Medical Access Uganda Limited:
$62,471,118
View countries